课题基金 / 基金详情

THE EFFECTS OF NALTREXONE ON ACTIVE CROHN'S DISEASE

THE EFFECTS OF NALTREXONE ON ACTIVE CROHN'S DISEASE
纳曲酮对活动性克罗恩病的影响
批准号:
7625800
负责人:
Jill P Smith
金额:
$1.67万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-04-01 至 2008-03-31

项目摘要

项目成果

Jill P Smith的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The hypothesis for this study is that oral naltrexone will improve inflammation of the bowel by increasing endogenous enkephalin levels in subjects with active Crohn's disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Phase 1 study to test safety and dose of proglumide as an anti-fibrotic agent
  • 批准号:
    10015244
  • 项目类别:
  • 资助金额:
    $26.25万
  • 财政年份:
    2019
  • 负责人:
    Jill P Smith
  • 依托单位:
Phase 1 study to test safety and dose of proglumide as an anti-fibrotic agent
  • 批准号:
    9808375
  • 项目类别:
  • 资助金额:
    $20.29万
  • 财政年份:
    2019
  • 负责人:
    Jill P Smith
  • 依托单位:
High fat diet stimulates pancreatic cancer through the actions of Cholecystokinin
  • 批准号:
    8969907
  • 项目类别:
  • 资助金额:
    $20.04万
  • 财政年份:
    2015
  • 负责人:
    Jill P Smith
  • 依托单位:
CLINICAL TRIAL: OGF & GEMCITABINE: NOVEL TREATMENT FOR PANCREATIC CANCER